rethinkPeptides Search
Menu
Study breakdown

Designing Artificial Cell-Penetrating Foldamers That Can Carry Drugs Into Cells

In_vitroPreliminary evidence
The takeaway

Cell-penetrating foldamers — synthetic oligomers with organized secondary structures — are being developed as drug delivery carriers with enhanced cell membrane permeability.

Foldamers

synthetic oligomers with organized secondary structures designed for enhanced cell penetration

What the researchers found

Cell-penetrating foldamers containing various non-natural building blocks can achieve organized secondary structures that enhance cell membrane permeability, functioning as potential drug delivery system (DDS) carriers.

Why it matters

Natural cell-penetrating peptides face stability and specificity challenges. Foldamers — being synthetic and designable — could overcome these limitations while maintaining or exceeding the cell-penetrating ability of natural CPPs.

The numbers in context

Multiple foldamer designs; optimal secondary structure and cationic content achieved efficient cell penetration.

How the study worked

Account/mini-review describing recent advances in designing cell-penetrating foldamers with various building blocks and their applications as drug delivery carriers.

Who was studied

Synthetic foldamer library tested in cell culture

What this study cannot tell us

Account/overview format with limited original data. Many foldamers discussed are at early proof-of-concept stage. In vivo performance, toxicity, and pharmacokinetics of most foldamers remain to be established.

How to read the evidence

Account summarizing design principles and early results. Conceptual framework is well-established but clinical applications remain distant.

When this study was published

Published in 2020. Foldamer design for drug delivery continues as an active area of peptidomimetic research.

The bigger picture

Drug delivery is a major bottleneck in medicine — many effective drugs can't reach their intracellular targets. Foldamers represent a designable, tunable platform for overcoming this barrier, bridging the gap between small molecule drugs and biological therapeutics.

Questions still open

  • Which foldamer building blocks provide the best balance of cell penetration and biocompatibility?
  • Can foldamers achieve tissue-specific delivery in vivo?
  • How do foldamers compare to natural CPPs in terms of cargo delivery efficiency and safety?

Common questions

What is a foldamer?
A foldamer is a synthetic chain of chemical building blocks that folds into a defined 3D shape, similar to how natural proteins fold. Unlike natural peptides, foldamers can be made from non-natural components for enhanced stability and function.
Why not just use natural cell-penetrating peptides?
Natural CPPs break down quickly in the body, can trigger immune responses, and are hard to optimize. Synthetic foldamers can be designed to resist degradation and be customized for specific delivery tasks.

Read the original research

De Novo Design of Cell-Penetrating Foldamers.

Chemical record (New York, N.Y.), 20(9), 912-921

Citation

Yokoo, Hidetomo; Misawa, Takashi; Demizu, Yosuke. (2020). De Novo Design of Cell-Penetrating Foldamers.. Chemical record (New York, N.Y.), 20(9), 912-921. https://doi.org/10.1002/tcr.202000047